It has previously been shown that obesity, presence of MetS and T2D -all pathogenic conditions accompanying insulin resistance- are associated with increased serum RBP4 levels [6], [32], although some studies have found no association between RBP4 and insulin resistance [9], [10], [12], [15]. The gene discussed is RBP4; the disease is type 2 diabetes mellitus.